Iraj Rasooli

11PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Biological adaptationInnate immunityRehabilitation engineeringBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2025
Loop 3 Repeats in Omp34 is a Promising Immunogen for Vaccine Development Against Acinetobacter baumannii Infections.

Roghayeh Bashiri, Abolfazl Jahangiri, Saeede Masoomkhani

|Apr 21, 2025
Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.

Seyedeh Faezeh Hosseini, Mohammadreza Jalali Nadoushan, Zahra Fekrirad

|Oct 31, 2024
Characterizing the interplay between Acinetobacter baumannii, A549 cells, and anti-Omp34 antibodies: implications for adherence, internalization, and cytotoxicity.

Masoomeh Rajabzadeh, Zahra Fekrirad, Mohammadreza Jalali Nadoushan

|Sep 03, 2024
Modulation with anti-Oma87 antibodies of cytotoxicity, adherence, and internalization of Acinetobacter baumannii in human cervical carcinoma epithelial cells.

Zahra Panji, Mohammadreza Jalali Nadoushan, Zahra Fekrirad

|Dec 24, 2022
Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model.

Ehsan Zare Banadkoki, Iraj Rasooli, Tooba Ghazanfari

|Jul 22, 2022
Specific egg yolk antibody raised to biofilm associated protein (Bap) is protective against murine pneumonia caused by Acinetobacter baumannii.

Azam Ranjbar, Iraj Rasooli, Abolfazl Jahangiri

Pageof 2

Frequent Collaborators

3 joint publications

Shakiba Darvish Alipour Astaneh

3 joint publications

Abolfazl Jahangiri

3 joint publications

Mohammadreza Jalali Nadoushan

2 joint publications

Parviz Owlia